| #82 |
Edgar Jacoby |
Johnson & Johnson |
1 |
| #82 |
Bertrand Sutter |
Novartis Ag |
1 |
| #82 |
Magdalena KOZICZAK-HOLBRO |
Novartis Ag |
1 |
| #82 |
Jürg Dreier |
Basilea Pharmaceutica Ag |
1 |
| #82 |
Thomas Mueller |
Bayer Cropscience |
1 |
| #82 |
David BALYA |
Friedrich Miescher Institute For Biomedical Research |
1 |
| #82 |
Ralf Petermann |
Huntsman International |
1 |
| #82 |
Gregor HUBER |
Basf Se |
1 |
| #82 |
Kevin Murer |
Huntsman International |
1 |
| #82 |
Michal Juricek |
King Abdulaziz City For Science And Technology |
1 |
| #82 |
Julia Jascur |
Novartis Ag |
1 |
| #82 |
Kevin Hall McAllister |
Novartis Ag |
1 |
| #82 |
Ian Jones |
Hoffmann-La Roche |
1 |
| #82 |
Fionn O'Hara |
Hoffmann-La Roche |
1 |
| #82 |
Margit Jeschke |
Novartis Ag |
1 |
| #82 |
Aline HUEBER |
Dsm Ip Assets B.V. |
1 |
| #82 |
Stephanie Portmann |
Basf Se |
1 |
| #82 |
Karsten Marx |
Polyphor Ag |
1 |
| #82 |
Cindy Gerhardt |
Dsm Ip Assets B.V. |
1 |
| #82 |
Rob Markus |
Dsm Ip Assets B.V. |
1 |
| #82 |
Thomas Tange Ostergaard |
Evolva Sa |
1 |
| #82 |
Tania Reina |
Hoffmann-La Roche |
1 |
| #82 |
Shaoning Wang |
Hoffmann-La Roche |
1 |
| #82 |
Timothée Vincent Maret |
Adobe |
1 |
| #82 |
Eva Rödel |
Intrexon |
1 |
| #82 |
Luca Regazzoni |
Depuy Synthes Products |
1 |
| #82 |
Horst Prescher |
— |
1 |
| #82 |
Eva Roedel |
Basf Se |
1 |
| #82 |
Catherine HAMELIN |
Dsm Ip Assets B.V. |
1 |
| #82 |
Ulrich Zutter |
Hoffmann-La Roche |
1 |
| #82 |
Gemma Veitch |
Basf Se |
1 |
| #82 |
Massimo Pignone |
Novartis Ag |
1 |
| #82 |
Doris Stingelin |
Novartis Ag |
1 |
| #82 |
Lukas Giger |
Depuy Synthes Products |
1 |
| #82 |
Vladimir Cmiljanovic |
University Of Basel |
1 |
| #82 |
Zorica DRAGIC |
Novartis Ag |
1 |
| #82 |
Marta Cosenza |
Novartis Ag |
1 |
| #82 |
Felipe José Oliveira Varum |
Tillotts Pharma Ag |
1 |
| #82 |
Masato Hoshino |
Nissan Motor Co. |
1 |
| #82 |
Heiner Bieli |
Straumann Holding Ag |
1 |
| #82 |
Denis Hug |
Dsm Ip Assets B.V. |
1 |
| #82 |
Ute Keck |
Morphosys Ag |
1 |
| #82 |
Urs Lehmann |
Ciba Specialty Chemicals |
1 |
| #82 |
Thomas Ullrich |
Novartis Ag |
1 |
| #82 |
Chikako Ogawa |
Eisai R&D Management Co. |
1 |
| #82 |
Shinji Hatakeyama |
Novartis Ag |
1 |
| #82 |
Kurt Laumen |
Novartis Ag |
1 |
| #82 |
Hasan Mohajeri |
Dsm Ip Assets B.V. |
1 |
| #82 |
Juerg Hunziker |
Novartis Ag |
1 |
| #82 |
Jerome Hert |
Hoffmann-La Roche |
1 |